Marinus Pharmaceuticals Stock Forecast
Marinus Pharmaceuticals stock price ended at $1.41 on Friday, after losing 1.06%.
(Updated on Apr 26, 2024)
The Marinus Pharmaceuticals stock price fell by -1.06% on the last day (Friday, 26th Apr 2024) from $1.42 to $1.41. During the last trading day the stock fluctuated 5.43% from a day low at $1.38 to a day high of $1.46. The price has fallen in 7 of the last 10 days and is down by -81.32% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -230 thousand shares and in total, 1 million shares were bought and sold for approximately $1.56 million.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.208 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -53.19% during the next 3 months and, with a 90% probability hold a price between $0.0972 and $3.17 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
MRNS Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 17.08%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Marinus Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.42 and $6.63. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Marinus Pharmaceuticals stock
Marinus Pharmaceuticals finds support from accumulated volume at $1.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0750 between high and low, or 5.43%. For the last week, the stock has had daily average volatility of 7.56%.
Marinus Pharmaceuticals is oversold on RSI14 (7). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (MRNS) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Marinus Pharmaceuticals to open at $1.41, and during the day (based on 14 day Average True Range), to move between $0.82 and $1.99, which gives a possible trading interval of +/-$0.587 (+/-41.77%) up or down from last closing price. If Marinus Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 83.54% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.41 (0.36%) than the support at $1.38 (1.78%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Marinus Pharmaceuticals stock A Buy?
Marinus Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -3.455 Sell Candidate Unchanged
Predicted Opening Price for Marinus Pharmaceuticals of Monday, April 29, 2024
| Fair opening price April 29, 2024 | Current price |
|---|---|
| $1.41 ( 0.593%) | $1.41 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for MRNS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.49 | 5.93 % | |
| R2 | 1.46 | 3.89 % | ||
| R1 | 1.44 | 2.63 % | ||
| Current price: | 1.41 | |||
| Support | S1 | 1.38 | -1.45 % | |
| S2 | 1.37 | -2.71 % | ||
| S3 | 1.34 | -4.74 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.48 | 4.98 % | |
| R2 | 1.44 | 2.49 % | ||
| R1 | 1.41 | 0.356 % | ||
| Current price | 1.41 | |||
| Support | S1 | 1.38 | -1.78% | |
| S2 | 1.30 | -7.47% | ||
| S3 | 1.20 | -14.59% |
FAQ
Click here for our free guide on how to buy Marinus Pharmaceuticals Stock.
